FI885330A - ESTRAR AV PHARMACOLOGICAL VERKSAMBO CARBOXYLSYROR. - Google Patents

ESTRAR AV PHARMACOLOGICAL VERKSAMBO CARBOXYLSYROR. Download PDF

Info

Publication number
FI885330A
FI885330A FI885330A FI885330A FI885330A FI 885330 A FI885330 A FI 885330A FI 885330 A FI885330 A FI 885330A FI 885330 A FI885330 A FI 885330A FI 885330 A FI885330 A FI 885330A
Authority
FI
Finland
Prior art keywords
verksambo
carboxylsyror
estrar
pharmacological
verksambo carboxylsyror
Prior art date
Application number
FI885330A
Other languages
Finnish (fi)
Other versions
FI885330A0 (en
Inventor
Andre Furlenmeier
Christian Hubschwerlen
Marc Montavon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI885330A0 publication Critical patent/FI885330A0/en
Publication of FI885330A publication Critical patent/FI885330A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI885330A 1987-11-24 1988-11-17 ESTRAR AV PHARMACOLOGICAL VERKSAMBO CARBOXYLSYROR. FI885330A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH457087 1987-11-24
CH316588 1988-08-25

Publications (2)

Publication Number Publication Date
FI885330A0 FI885330A0 (en) 1988-11-17
FI885330A true FI885330A (en) 1989-05-25

Family

ID=25692354

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885330A FI885330A (en) 1987-11-24 1988-11-17 ESTRAR AV PHARMACOLOGICAL VERKSAMBO CARBOXYLSYROR.

Country Status (14)

Country Link
EP (1) EP0318767A3 (en)
JP (1) JPH01165585A (en)
KR (1) KR890008082A (en)
AU (1) AU614793B2 (en)
DK (1) DK637888A (en)
FI (1) FI885330A (en)
HU (1) HU207522B (en)
IL (1) IL88403A0 (en)
MC (1) MC1991A1 (en)
NO (1) NO885221L (en)
NZ (1) NZ226989A (en)
PT (1) PT89080B (en)
SU (1) SU1598880A3 (en)
YU (2) YU216188A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99898A (en) * 1990-11-09 1996-10-31 Eisai Co Ltd 7-Acyl-3-substituted carbamoyloxy cephem compounds their preparation and antibacterial compositions containing them
BR9608318A (en) * 1995-05-03 1999-01-26 Smithkline Beecham Plc Carbapenem esters
JP2014525459A (en) * 2011-08-31 2014-09-29 マリンクロッド エルエルシー Remote assembly of targeted nanoparticles using H-phosphonate-ene / H-phosphonate-inhydrophosphonylation reaction
MX352760B (en) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Methods for treating intrapulmonary infections.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (en) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (en) * 1980-02-18 1981-08-21 Roussel Uclaf NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
JPS5984889A (en) * 1982-11-05 1984-05-16 Sumitomo Chem Co Ltd Cephalosporin derivative and its preparation

Also Published As

Publication number Publication date
MC1991A1 (en) 1989-11-30
HU207522B (en) 1993-04-28
DK637888D0 (en) 1988-11-15
YU216188A (en) 1990-04-30
EP0318767A2 (en) 1989-06-07
KR890008082A (en) 1989-07-08
YU191589A (en) 1991-02-28
EP0318767A3 (en) 1991-03-20
SU1598880A3 (en) 1990-10-07
NZ226989A (en) 1992-05-26
NO885221L (en) 1989-05-25
IL88403A0 (en) 1989-06-30
AU614793B2 (en) 1991-09-12
NO885221D0 (en) 1988-11-23
DK637888A (en) 1989-05-25
JPH01165585A (en) 1989-06-29
HUT48895A (en) 1989-07-28
PT89080B (en) 1993-04-30
PT89080A (en) 1988-12-01
AU2578588A (en) 1989-05-25
FI885330A0 (en) 1988-11-17

Similar Documents

Publication Publication Date Title
FI880280A0 (en) FOERFARANDE FOER PRODUCERING AV ICKE-NATURLIGA DEMETYLAVERMEKTINER.
FI881841A0 (en) SLAGBORR FOER AOSTADKOMMANDE AV BORRHAOL.
FI882063A (en) FRAMSTAELLNING AV EN KATALYSATORKOMPONENT FOER OLEFINPOLYMERISATION.
FI881346A (en) FOERFARANDE FOER STYRNING AV EN ELEKTROSTATISK BESKIKTNINGSANORDNING.
FI880481A0 (en) FOERFARANDE FOER VATTENBESTAENDIGGOERANDE AV STAERKELSEBINDEMEDEL.
FI885330A0 (en) ESTRAR AV PHARMACOLOGICAL VERKSAMBO CARBOXYLSYROR.
FI881617A0 (en) GENTEKNOLOGISKT FOERFARANDE FOER FRAMSTAELLNING AV POLYPEPTIDER.
FI873499A (en) FOERFARANDE FOER FRAKTIONERING AV SPANNMAOL SAOSOM INDUSTRIELLT RAOMATERIAL.
FI883457A0 (en) FOERFARANDE FOER REDUKTION AV KETONER.
FI881146A (en) FOERFARANDE FOER FOERBAETTRING AV PAPPRETS HAOLLFASTHET.
FI870360A0 (en) NYTT FOERFARANDE FOER FRAMSTAELLNING AV SODRIUMKARBOXIMETYLCELLULOSA.
FI883362A0 (en) BOMBERING AV GLASSKIVOR.
FI882609A (en) FOERFARANDE FOER FRAMSTAELLNING AV 4-NITRO-5-IMIDAZOLYLETRAR OCH -TIOETRAR.
FI884351A0 (en) DESINFEKTERING AV FORMAVTRYCK.
FI874873A0 (en) FOERFARANDE FOER AVLAEGSNING AV SVAVELOXIDER FRAON ROEKGASER.
FI885359A (en) PLANETHJULSVAEXEL AV PRECESSIONSTYP.
FI870963A0 (en) FOERFARANDE FOER PLANTERING AV PLANTOR.
FI870122A (en) KJJUGAT AV BIOLOGISKA MOLEKYLER.
FI892662A (en) UNDERSOEKNING AV VAETSKORS EGENSKAPER.
FI890782A0 (en) FRIGOERNINGSSYSTEM FOER PHARMACOLOGICAL AEMNEN.
FI873760A0 (en) ANORDNING FOER KOMPOSTERING AV ORGANISKT AVFALL.
FI871009A0 (en) ANORDNING FOER KRAFTTRAENING AV MUSKLER.
FI874209A0 (en) ANORDNING FOER PLACERING AV LOKALISERINGSTECKEN.
FI870075A0 (en) FYLLNINGS- OCH BRYTNINGSANORDNING FOER EN AV PLASTFOLIE OMGIVEN PLANTKLIMP.
FI872462A (en) FOERFARANDE FOER FRAMSTAELLNING AV EN HAERDBAR KOMPOSITION.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: F. HOFFMANN-LA ROCHE AG